Begin with the exact question
A study is built to answer a defined question. For many intervention studies, that question can be separated into the population studied, the intervention, the comparison, and the outcome—often shortened to PICO.
Time and setting matter too. A twelve-week comparison in a narrowly selected group is not the same question as a two-year comparison in a broad population, even when both studies examine the same compound.
Who was studied sets the population boundary
Eligibility criteria tell us who could enter the study. The participant table tells us who actually did. Age, health conditions, disease severity, prior treatment, and other characteristics can affect how well the result applies elsewhere.
A result can be internally credible and still have limited reach. If a study enrolled only one narrow group, extending the conclusion to substantially different people requires additional support.
The measured outcome is the result—not the hoped-for outcome
An outcome is the specific measurement used to evaluate what changed. Primary outcomes are selected to address the study’s main objective; secondary outcomes add other planned questions; exploratory analyses are generally used to generate or investigate possibilities.
A change in a laboratory marker is a result about that marker. It is not automatically a result about symptoms, daily function, long-term health, or any other outcome that was not directly measured. A surrogate outcome may be useful, but its ability to predict a patient-relevant outcome must be supported separately.
Read the size and uncertainty—not only the direction
The effect estimate describes the size and direction of the measured difference or association. A confidence interval shows a range of effect values compatible with the study result under the model used and helps reveal how precise or imprecise the estimate is.
A p-value does not tell us how large or important an effect is, and it does not determine whether the finding matters in practice. Statistical evidence, effect size, uncertainty, study quality, and the meaning of the outcome all belong in the interpretation.
The design sets a ceiling on the conclusion
When a randomized trial is designed, conducted, and analyzed well, random assignment helps reduce confounding and can support a causal conclusion about the measured outcome. Randomization does not remove every possible source of bias or make every result broadly applicable.
An observational study can identify an association in the observed data. If other factors influence both the exposure or treatment and the outcome, that association may differ from the true causal effect. Cell and animal studies can answer valuable biological questions, but they do not directly establish an outcome in people.
Ask how far the conclusion traveled
A careful conclusion stays close to the design, population, comparison, outcome, timeframe, and uncertainty. A headline often removes one or more of those boundaries because the broader version is easier to repeat.
The useful question is not only “Was the result positive?” It is “What precise claim does this result support—and which parts of the larger question remain unanswered?”
Key terms
- Population
- The people, animals, cells, or samples included in the study.
- Comparator
- What the intervention or exposure is compared with, such as placebo, usual care, another intervention, or no exposure.
- Outcome
- The specific result a study measures at a defined time point.
- Effect estimate
- A numerical description of the size and direction of a difference or association.
- Confidence interval
- A range that communicates uncertainty around an estimate under the statistical model used.
- Confounding
- Distortion that occurs when another factor is related to both the exposure or treatment and the outcome.
Relay diagram
Translate the study before expanding the claim
What this can—and cannot—tell us
What it can tell us
- What was observed in the studied population or system under the stated conditions.
- The size, direction, and reported uncertainty of the outcomes that were measured.
- Whether the design supports a causal conclusion, an association, or a more preliminary signal.
- Which questions deserve confirmation or further study.
What it cannot establish alone
- What happened to an outcome the study did not measure.
- That the same result applies to every person, setting, dose, route, or timeframe.
- Cause and effect when the design and analysis support only an association.
- That no important harm exists because a short or small study did not detect one.
- That one result settles the entire evidence record.
Go deeperOptional · about 2 minutes
Why the protocol matters
A study protocol and statistical analysis plan describe the intended questions and analyses before the results are known. Comparing them with the final report helps distinguish prespecified outcomes from analyses chosen or emphasized afterward.
Post-hoc and exploratory analyses can generate valuable hypotheses. They become misleading when presented with the same certainty as a prespecified, appropriately analyzed primary result.
Why statistical significance is not the finish line
The American Statistical Association warns that a p-value does not measure the probability that a hypothesis is true, the size of an effect, or the importance of a result. A threshold can help control a decision rule, but it cannot replace scientific judgment.
Effect estimates and confidence intervals usually carry more of the information a reader needs: the direction, possible magnitude, and precision of the result. For binary outcomes, absolute and relative effects can also create very different impressions of the same data, so both may be needed.
Why benefit and harm may require different evidence
A trial can be large enough to detect a common short-term benefit yet too small or too brief to detect an uncommon or delayed harm. No statistically significant difference in harms is not the same as proof that the risks are identical.
Harms may require longer follow-up, larger populations, observational evidence, active surveillance, or evidence from multiple studies. The right design depends on the question.
The takeaway
If you only remember one thing from this guide:
One study answers a specific question. It rarely answers every question.
Sources and support8 sources
- Cochrane Handbook, Chapter 2: Determining the scope of the review and the questions it will address Cochrane
Explains how intervention questions are structured around population, intervention, comparison, and outcomes.
- Results Data Element Definitions ClinicalTrials.gov
Defines prespecified outcome measures and distinguishes primary, secondary, and post-hoc measures.
Specifies transparent reporting of participants, prespecified outcomes, effect estimates, precision, and harms.
Explains how randomization addresses confounding and why other bias domains still matter.
Explains how confounding can make an observed association differ from a causal effect.
- ASA Statement on Statistical Significance and P-Values American Statistical Association
States that p-values do not measure effect size, practical importance, or the probability that a hypothesis is true.
- Multiple Endpoints in Clinical Trials U.S. Food and Drug Administration
Explains primary, secondary, and exploratory endpoints and the risk of false conclusions from unaddressed multiplicity.
Explains why adverse effects may require different study designs and evidence sources than intended benefits.